Reference is made to the announcement made on 28 August 2017 by Statoil ASA (OSE:STL, NYSE:STO) regarding the dividend issue for the first quarter 2017 ("the Dividend Issue").
The Subscription Price shall, in accordance with the resolution made by the board of directors on 26 July 2017, be equal to the volume-weighted average share price over the last two trading days (7 and 8 September 2017) on Oslo Børs ("Oslo Stock Exchange") of the Subscription Period for the Dividend Issue, with a deduction of a discount of 5%.
The volume-weighted average share price for the respective trading days was NOK 148.55. The Subscription Price per share is consequently NOK 141.12.
The subscription price for the ADR holders will be equal to the Subscription Price converted into USD using the Central Bank of Norway's average closing exchange rate of the last two trading days of the Subscription Period, i.e. 7 and 8 September 2017. The average exchange rate for these respective days was 7.7414. The subscription price per share for ADR-holders is consequently USD 18.23.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This announcement and the information contained herein does not constitute or form a part of, and should not be construed as, an offer for sale or subscription for or solicitation or invitation of any offer to subscribe for or purchase of dividend shares or any other securities of the Company and cannot be relied on for any investment contract or decision.
It may be unlawful to distribute this announcement in certain jurisdictions. This announcement is not for distribution in any jurisdiction in which prior registration or approval is required for that purpose. No steps have been taken or will be taken in any jurisdiction outside of Norway in which such steps would be required. No competent authority or any other regulatory body has passed upon the adequacy of this document or approved or disapproved the distribution of dividend shares outside of Norway. Any representation to the contrary may be a criminal offense.


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Italy Fines Apple €98.6 Million Over App Store Dominance
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 



